<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The involvement of reactive oxygen species in various diseases has been demonstrated almost in vitro or in animal studies and clinical studies supporting the involvement of reactive oxygen species are very few </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="16990">Bilirubin</z:chebi> has been recognized as an important <z:chebi fb="11" ids="22586">antioxidant</z:chebi> and also shown to have an inhibitory effect on the activity of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase, which may be an important source for <z:chebi fb="1" ids="18421">superoxide</z:chebi> production in various tissues </plain></SENT>
<SENT sid="2" pm="."><plain>When the prevalence of vascular complcations was compared in diabetic patients with and without a congenital <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> (<z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e>), the prevalence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, macroalbuminuria and <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> in patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e> was about 20% of that in those without <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>For study of lifestyle-related diseases, the Fukuoka Cohort was constructed from 2003 to 2009 in Kyushu area in Japan, which contains a total of 12,949 persons </plain></SENT>
<SENT sid="4" pm="."><plain>Cross-sectional study of the Fukuoka Cohort revealed an inverse relation between serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> level and the prevalence of type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>A precursor of <z:chebi fb="0" ids="16990">bilirubin</z:chebi>, <z:chebi fb="0" ids="17033">biliverdin</z:chebi>-treated db/db mice exhibited less <z:mp ids='MP_0002871'>albuminuria</z:mp> and nephropathic changes </plain></SENT>
<SENT sid="6" pm="."><plain>These effects were paralleled with normalization of <z:mp ids='MP_0003674'>oxidative stress</z:mp> markers and expression of <z:chebi fb="0" ids="13392">NAD(P)H</z:chebi> oxidase subunits in kidney </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggested that <z:mp ids='MP_0003674'>oxidative stress</z:mp> is an exacerbating factor of type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and that <z:chebi fb="11" ids="22586">antioxidant</z:chebi> therapies are of value to diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
</text></document>